On March 30, 2023, Canaccord Genuity upgraded their outlook for Globus Medical (NYSE:GMED) from Hold to Buy. Analyst Price Forecast Suggests 28.13% Upside As of March 30, 2023, the average one-year …
More Canaccord Genuity Upgrades Globus Medical (GMED) Videos